TECNO Demonstrates the Deep Customization Potential of Mobile AI with Tailored EllaClaw Agentic Workflows
September 23, 2026

BEIJING, Sept. 22, 2026 /PRNewswire/ -- A report...


HONG KONG, Sept. 22, 2026 /PRNewswire/ -- Today,...

DEEp SEA is a global Phase III trial evaluating efficacy, safety and...

First FDA-approved stent designed specifically for the smallest patients with certain congenital...

Anti-B7-H3 antibody-drug conjugate reduced the risk of death by 54% versus topotecan...

Ribbon-cutting held on World Suicide Prevention DayRED BANK, N.J., Sept. 12, 2026...






